drug: pergolide
- Clinical class: Anti-Parkinsonian
- Chemical class: ergot alkaloid
- Action: dopamine agonist
- CSA schedule: none
- DEA number: none
U.S. Preparations:
- Permax® (Elan) FDA approved indications: adjunct in treatment of
Parkinson's disease 12.30.1988
U.S. Prescribing information
Preparations Outside U.S.:
- Celance, Nopar, Parkotil, Pharken